摘要
目的 探讨阿奇霉素在治疗儿童肺炎支原体肺炎(M P)中的疗效。方法:采用间接固相酶联免疫吸附(ELISA)技术,血清效价>1∶80,确诊为 M P 感染。结果: 例患儿均有呼吸道表现,61 例患儿有肺外脏器受累。全部病例经阿奇霉素治疗 4 周痊愈,无复发。 117结论:阿奇霉素具有高效、广谱、不良反应少,耐药性好的特点,尤其对小儿支原体肺炎。
Objective: To study the therapeutic effects of azithromycin in treatment of mycoplasma pneumoniae pneumonia in children. Methods: Enzyme-linked immunosorbent assay (ELISA) technique adopted, when serum effect price ratio >1∶80, MP infection was determined. Results: All of the 117 cases had breath symptoms. Among them, 61 cases had internal organ diseases. All cases treated with azithromycin were reviewed without relapsing. Conclusion: The result of the study showed that oral azithromycin had significant therapeutic effects with little side effect and was well tolerated. Azithromycin may become an alternative therapy in treatment of mycoplasma pneumoniae pneumonia in children.
出处
《儿科药学杂志》
CAS
2004年第2期49-50,共2页
Journal of Pediatric Pharmacy
关键词
阿奇霉素
治疗
儿童
支原体肺炎
疗效观察
Azithromycin
Children
Mycoplasma pneumoniae pneumonia
Therapeutic effects
